240 related articles for article (PubMed ID: 27694612)
1. Establishing the colitis-associated cancer progression mouse models.
Zheng H; Lu Z; Wang R; Chen N; Zheng P
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):759-763. PubMed ID: 27694612
[TBL] [Abstract][Full Text] [Related]
2. Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model.
Huo X; Liu D; Gao L; Li L; Cao L
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563884
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-β protects against colitis-associated neoplasia in mice.
Saleiro D; Murillo G; Benya RV; Bissonnette M; Hart J; Mehta RG
Int J Cancer; 2012 Dec; 131(11):2553-61. PubMed ID: 22488198
[TBL] [Abstract][Full Text] [Related]
4. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
[TBL] [Abstract][Full Text] [Related]
5. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).
Thaker AI; Shaker A; Rao MS; Ciorba MA
J Vis Exp; 2012 Sep; (67):. PubMed ID: 22990604
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
[TBL] [Abstract][Full Text] [Related]
7. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.
Xu YL; Ding CL; Qian CL; Qi ZT; Wang W
Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898
[TBL] [Abstract][Full Text] [Related]
8. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
9. Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization.
Chen Y; Wang B; Yuan X; Lu Y; Hu J; Gao J; Lin J; Liang J; Hou S; Chen S
Phytomedicine; 2021 Mar; 83():153489. PubMed ID: 33571919
[TBL] [Abstract][Full Text] [Related]
10. The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
Angelou A; Papalois AE; Antoniou E; Wang J; Amini N; Pikouli A; Andreatos N; Buettner S; Munir M; Theodoropoulos G; Zografos GC; Sarantis P; Pulvirenti A; Kamphues C; Theocharis S; Pikoulis E; Margonis GA
Anticancer Res; 2020 Oct; 40(10):5457-5462. PubMed ID: 32988867
[TBL] [Abstract][Full Text] [Related]
11. Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage.
Amini-Khoei H; Momeny M; Abdollahi A; Dehpour AR; Amiri S; Haj-Mirzaian A; Tavangar SM; Ghaffari SH; Rahimian R; Mehr SE
Int Immunopharmacol; 2016 Jul; 36():9-16. PubMed ID: 27104313
[TBL] [Abstract][Full Text] [Related]
12. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
13. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
[TBL] [Abstract][Full Text] [Related]
14. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model.
Gao Y; Li X; Yang M; Zhao Q; Liu X; Wang G; Lu X; Wu Q; Wu J; Yang Y; Yang Y; Zhang Y
Carcinogenesis; 2013 Aug; 34(8):1861-9. PubMed ID: 23615396
[TBL] [Abstract][Full Text] [Related]
15. AOM/DSS Model of Colitis-Associated Cancer.
Parang B; Barrett CW; Williams CS
Methods Mol Biol; 2016; 1422():297-307. PubMed ID: 27246042
[TBL] [Abstract][Full Text] [Related]
16. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
17. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
18. Increased Genetic Instability and Accelerated Progression of Colitis-Associated Colorectal Cancer through Intestinal Epithelium-specific Deletion of
Yang VW; Liu Y; Kim J; Shroyer KR; Bialkowska AB
Mol Cancer Res; 2019 Jan; 17(1):165-176. PubMed ID: 30108164
[TBL] [Abstract][Full Text] [Related]
19. An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research.
Wang F; Johnson RL; Snyder PW; DeSmet ML; Fleet JC
Dig Dis Sci; 2016 Apr; 61(4):1069-79. PubMed ID: 26631394
[TBL] [Abstract][Full Text] [Related]
20. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
Sakurai T; Kashida H; Watanabe T; Hagiwara S; Mizushima T; Iijima H; Nishida N; Higashitsuji H; Fujita J; Kudo M
Cancer Res; 2014 Nov; 74(21):6119-28. PubMed ID: 25187386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
